Rafa Laboratories Ltd.

Rafa Laboratories is a global leader in biodefense and emergency medical solutions. For more than 40 years, Rafa has supplied medical countermeasure (MCM) autoinjectors to the Israeli Defense Forces, U.S. federal government, NATO allies, military forces, and civilian stockpiles worldwide.
Rafa is focused on developing and commercializing medical countermeasures for CBRN threats, including treatments for nerve agents and fentanyl poisoning. In addition, Rafa has an emerging trauma care pipeline, which includes morphine and ketamine autoinjectors for acute pain management/analgesia, as well as a new treatment for major bleeding in the form of Intramuscular TXA.
Rafa is a one stop shop for several major acute care needs with demonstrated expertise in the development, US FDA approval, large-scale manufacturing, and reliable supply of MCM autoinjectors, with the capacity to support surge procurement due to urgent government requirements.